CERRITOS, Calif., June 27, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based oncology groups in the United States, announced today the signing of an expanded partnership agreement with McKesson Corporation (“McKesson”) for
CERRITOS, Calif., June 21, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that its Chief Executive Officer, Brad Hively, will participate in the “Value-Based Care for Medicare” panel at the
CERRITOS, Calif., June 07, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that it will join the Russell 2000 Ò and Russell 3000 Ò Indexes after the 2022 Russell indexes annual reconstitution,
The company is making world-class, community-based cancer care more accessible to Texas residents AUSTIN, Texas, June 02, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, is expanding its footprint into Austin,
CERRITOS, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Brad Hively, Chief Executive Officer, will participate at the following investor conferences: UBS Healthcare
CERRITOS, Calif., May 11, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, today reported financial results for its first quarter ended March 31, 2022. "We are pleased with the results we achieved in
TOI welcomes women’s specialty practice to expand into California’s Central Valley FRESNO, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, recently acquired Women’s Cancer
CERRITOS, Calif., April 20, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”)(NASDAQ: TOI) today announced that the company will release its first quarter results after the market close on Wednesday, May 11, 2022, to be followed by a conference call the same day 5:00 p.m. (Eastern Time).
Savings equated to nearly $4,000 per patient episode in most recent OCM performance period CERRITOS, Calif., April 07, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, continues to support the
Shah Brings 15 Years of Financial Leadership in Public and Private Healthcare Companies CERRITOS, Calif., April 04, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI) today announced the appointment of Mihir Shah as chief financial officer, effective immediately.